Bioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loading
FY Han, KJ Thurecht, AK Whittaker… - Frontiers in …, 2016 - frontiersin.org
Poly (lactic-co-glycolic acid)(PLGA) is the most widely used biomaterial for
microencapsulation and prolonged delivery of therapeutic drugs, proteins and antigens …
microencapsulation and prolonged delivery of therapeutic drugs, proteins and antigens …
Vitamin E TPGS as a molecular biomaterial for drug delivery
Z Zhang, S Tan, SS Feng - Biomaterials, 2012 - Elsevier
d-α-tocopheryl polyethylene glycol succinate (Vitamin E TPGS, or simply TPGS) is a water-
soluble derivative of natural Vitamin E, which is formed by esterification of Vitamin E …
soluble derivative of natural Vitamin E, which is formed by esterification of Vitamin E …
Current advances in research and clinical applications of PLGA-based nanotechnology
JM Lü, X Wang, C Marin-Muller, H Wang… - Expert review of …, 2009 - Taylor & Francis
Co-polymer poly (lactic-co-glycolic acid)(PLGA) nanotechnology has been developed for
many years and has been approved by the US FDA for the use of drug delivery, diagnostics …
many years and has been approved by the US FDA for the use of drug delivery, diagnostics …
[HTML][HTML] Paclitaxel nano-delivery systems: a comprehensive review
P Ma, RJ Mumper - Journal of nanomedicine & nanotechnology, 2013 - ncbi.nlm.nih.gov
Paclitaxel is one of the most effective chemotherapeutic drugs ever developed and is active
against a broad range of cancers, such as lung, ovarian, and breast cancers. Due to its low …
against a broad range of cancers, such as lung, ovarian, and breast cancers. Due to its low …
Vitamin E TPGS-based nanomedicine, nanotheranostics, and targeted drug delivery: past, present, and future
It has been seventy years since a water-soluble version of vitamin E called tocophersolan
(also known as TPGS) was produced; it was approved by USFDA in 1998 as an inactive …
(also known as TPGS) was produced; it was approved by USFDA in 1998 as an inactive …
Nanoscale drug delivery systems for cancer therapy using paclitaxel—A review of challenges and latest progressions
Paclitaxel (PTX) is an effective anticancer chemical with a broad spectrum that was primarily
obtained from a curative shrub, specifically the bark of Taxus brevifolia tree. It belongs to a …
obtained from a curative shrub, specifically the bark of Taxus brevifolia tree. It belongs to a …
A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants
A Xu, M Yao, G Xu, J Ying, W Ma, B Li… - International journal of …, 2012 - Taylor & Francis
Background The aim of this work was to improve oral bioavailability. The uptake of a series
of quaternary ammonium salt didodecyl dimethylammonium bromide (DMAB)-modified …
of quaternary ammonium salt didodecyl dimethylammonium bromide (DMAB)-modified …
Peptide-based hydrogel nanoparticles as effective drug delivery agents
R Ischakov, L Adler-Abramovich, L Buzhansky… - Bioorganic & medicinal …, 2013 - Elsevier
Peptide-based hydrogel nanoparticles represent a promising alternative to current drug
delivery approaches. We have previously demonstrated that the Fmoc-FF aromatic dipeptide …
delivery approaches. We have previously demonstrated that the Fmoc-FF aromatic dipeptide …
[HTML][HTML] Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective
A Nakhlband, M Eskandani, Y Omidi, N Saeedi… - BioImpacts …, 2018 - ncbi.nlm.nih.gov
An external file that holds a picture, illustration, etc. Object name is bi-8-59-g004. jpg
Introduction: Cardiovascular diseases (CVDs) is recognized as the leading cause of …
Introduction: Cardiovascular diseases (CVDs) is recognized as the leading cause of …
Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration
Malignant gliomas are highly lethal. Delivering chemotherapeutic drugs to the brain in
sufficient concentration is the major limitation in their treatment due to the blood-brain barrier …
sufficient concentration is the major limitation in their treatment due to the blood-brain barrier …